Cresco Labs Creates Wellness Subsidiary, Enters Hemp-CBD Space

Chicago-based cannabis cultivator, processor and retailer Cresco Labs CRLBF is launching a subsidiary focused on hemp-derived CBD wellness products that will allow the company to expand across all 50 U.S. states.

What Happened

The subsidiary, Well Beings, will provide a full line of CBD wellness products, according to Cresco. It will have a unique product line as well as CBD products under the Cresco, Remedi, and Mindy's Edibles brands. 

Cresco's new subsidiary will be led by its Chief Experience Officer Scott Wilson, who previously served as a creative director at Nike Inc NKE

The Cannabis Capital Conference is coming back to Toronto April 17-18!

Why It's Important

In December, the U.S. legalized industrial hemp and hemp-derived CBD on a federal level, creating a major opportunity for companies operating in the CBD space. 

New Frontier Data estimates the U.S. hemp-derived CBD market will expand from $390 million in 2018 to $1.3 billion in 2022. This represents a 27.2-percent five-year CAGR. 

What's Next

Cresco Labs said it will make a non-material investment in its new subsidiary. Well Beings plans to sell its products nationwide in retail and grocery stores, nutrition stores and online. 

Related Links:

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

New York City Bans CBD Edibles: What Now?

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsCBDCBD ProductsCresco LabsHempScott WillsonWell Beings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.